glp 1 liver function Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty disease GLP-1_receptor_som_behandling_af_steatotisk_leversygdom - SDU

Importantly, their influence extends to skeletal muscle, where GLP-1 RAs promote glucose uptake via the AMP-activated protein kinase pathway, increase vascular blood flow, and mitigate glucotoxicity, thereby supporting muscle protein synthesis and inhibiting catabolic pathways [14, 15]

PubMed Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease Useful when liver-fat claims involve next-generation incretin or pipeline agents

Digestive side effects such as nausea, vomiting, diarrhoea, constipation, bloating and burping may gradually improve once treatment is stopped, but this can vary from person to person

Stripped of all meaning, GLP-1 can be used to sell just about anything